Chemed Corp. (NYSE:CHE) has been given an average rating of “Hold” by the six ratings firms that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $236.00.

Several analysts have commented on CHE shares. Zacks Investment Research cut Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, September 13th. Oppenheimer Holdings, Inc. lifted their price target on Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Thursday, July 27th. TheStreet cut Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Royal Bank Of Canada restated a “hold” rating and issued a $209.00 price target on shares of Chemed Corp. in a report on Friday, September 1st. Finally, KeyCorp started coverage on Chemed Corp. in a report on Monday, August 28th. They issued a “sector weight” rating for the company.

ILLEGAL ACTIVITY WARNING: “Chemed Corp. (CHE) Given Consensus Recommendation of “Hold” by Brokerages” was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2017/11/03/chemed-corp-che-given-consensus-recommendation-of-hold-by-brokerages.html.

In other news, Director Patrick P. Grace sold 500 shares of Chemed Corp. stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $201.48, for a total value of $100,740.00. Following the transaction, the director now directly owns 4,515 shares of the company’s stock, valued at approximately $909,682.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Naomi C. Dallob sold 750 shares of Chemed Corp. stock in a transaction dated Tuesday, October 31st. The shares were sold at an average price of $222.09, for a total value of $166,567.50. Following the completion of the transaction, the vice president now directly owns 9,097 shares in the company, valued at $2,020,352.73. The disclosure for this sale can be found here. Insiders sold a total of 12,250 shares of company stock worth $2,698,968 over the last ninety days. Corporate insiders own 4.90% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CHE. Teachers Advisors LLC lifted its stake in shares of Chemed Corp. by 3.0% in the 1st quarter. Teachers Advisors LLC now owns 30,431 shares of the company’s stock valued at $5,559,000 after purchasing an additional 894 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Chemed Corp. by 30.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 3,650 shares of the company’s stock valued at $668,000 after purchasing an additional 854 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in shares of Chemed Corp. by 8.4% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 104,691 shares of the company’s stock valued at $19,126,000 after purchasing an additional 8,121 shares in the last quarter. Bank of America Corp DE lifted its position in Chemed Corp. by 19.2% during the 1st quarter. Bank of America Corp DE now owns 144,151 shares of the company’s stock worth $26,335,000 after acquiring an additional 23,261 shares in the last quarter. Finally, State Street Corp lifted its position in Chemed Corp. by 9.1% during the 1st quarter. State Street Corp now owns 445,367 shares of the company’s stock worth $81,370,000 after acquiring an additional 37,085 shares in the last quarter. 97.24% of the stock is currently owned by institutional investors and hedge funds.

Chemed Corp. (NYSE:CHE) last posted its quarterly earnings results on Thursday, October 26th. The company reported $2.15 EPS for the quarter, beating the consensus estimate of $2.00 by $0.15. The company had revenue of $417.40 million during the quarter, compared to analysts’ expectations of $414.34 million. Chemed Corp. had a return on equity of 27.69% and a net margin of 4.62%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.73 EPS.

Chemed Corp. Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.